Inventor · disambiguated record
Scott Jeffrey
Also filed as: JEFFREY SCOTT · JEFFREY SCOTT C · JEFFREY SCOTT CHARLES
34 granted patents·23 pending applications·968 citations·filing 2002–2025
98Inventor score
Top patents by PatentIndex Score
57 records- 0199US8039273B2β-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2006·Granted Oct 18, 2011·94 cites·27 claims
- 0299US7553816B2p-amidobenzylethers in drug delivery agentsSEATTLE GENETICS INC·Filed 2002·Granted Jun 30, 2009·178 cites·51 claims
- 0398US9713647B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 25, 2017·26 cites·10 claims
- 0498US8697688B2Pyrrolobenzodiazepines used to treat proliferative diseasesHOWARD PHILIP WILSON·Filed 2011·Granted Apr 15, 2014·155 cites·7 claims
- 0598US8568728B2Beta-glucuronide-linker drug conjugatesJEFFREY SCOTT·Filed 2011·Granted Oct 29, 2013·105 cites·25 claims
- 0697US9242013B2Targeted pyrrolobenzodiazapine conjugatesHOWARD PHILIP WILSON·Filed 2011·Granted Jan 26, 2016·78 cites·41 claims
- 0796US9592240B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Mar 14, 2017·23 cites·11 claims
- 0896US9526798B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Dec 27, 2016·21 cites·4 claims
- 0996US8163551B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2009·Granted Apr 24, 2012·48 cites·64 claims
- 1095US9707301B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2016·Granted Jul 18, 2017·21 cites·10 claims
- 1194US9387259B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2012·Granted Jul 12, 2016·24 cites·22 claims
- 1293US9816069B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2015·Granted Nov 14, 2017·6 cites·20 claims
- 1393US8993326B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2013·Granted Mar 31, 2015·9 cites·20 claims
- 1493US8871720B2Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminusDORONINA SVETLANA O·Filed 2006·Granted Oct 28, 2014·29 cites·11 claims
- 1592US9732084B2Pyrrolobenzodiazepines used to treat proliferative diseasesMEDIMMUNE LTD·Filed 2013·Granted Aug 15, 2017·19 cites·19 claims
- 1692US9399073B2PyrrolobenzodiazepinesMEDIMMUNE LTD·Filed 2012·Granted Jul 26, 2016·24 cites·17 claims
- 1791US8574907B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationALLEY STEPHEN C·Filed 2012·Granted Nov 5, 2013·19 cites·27 claims
- 1890US6777432B1Pharmaceutical uses and synthesis of nicotinamidesDARWIN MOLECULAR CORP·Filed 2002·Granted Aug 17, 2004·22 cites·50 claims
- 1989US7176310B1Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agentsUCB SA·Filed 2003·Granted Feb 13, 2007·29 cites·11 claims
- 2088US11319526B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2019·Granted May 3, 2022·2 cites·63 claims
- 2188US10561739B2Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2019·Granted Feb 18, 2020·4 cites·22 claims
- 2288US2024252672A1Beta-glucuronide-linker drug conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 2387US10443035B2Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEATTLE GENETICS INC·Filed 2017·Granted Oct 15, 2019·2 cites·12 claims
- 2486US9731030B2β-glucuronide-linker drug conjugatesJEFFREY SCOTT·Filed 2013·Granted Aug 15, 2017·5 cites·12 claims
- 2586US9587019B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2013·Granted Mar 7, 2017·7 cites·28 claims
- 2683US11116847B2Methylene carbamate linkers for use with targeted-drug conjugatesSEAGEN INC·Filed 2014·Granted Sep 14, 2021·3 cites·53 claims
- 2783US10328084B2Pyrrolobenzodiazepines and targeted conjugatesSEATTLE GENETICS INC·Filed 2017·Granted Jun 25, 2019·1 cites·15 claims
- 2883USRE45272Eβ-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2013·Granted Dec 2, 2014·3 cites·50 claims
- 2980US2023055475A1Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationSEAGEN INC·Filed 2022·Application pending·0 cites
- 3079US9522194B2Methods of using monomethylvaline compositions having phenylalanine carboxy modifications at the C-terminusSEATTLE GENETICS INC·Filed 2014·Granted Dec 20, 2016·1 cites·12 claims
- 3178US10787514B2CD33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2017·Granted Sep 29, 2020·1 cites·24 claims
- 3278US2022143209A1Beta-glucuronide-linker drug conjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 3377US7151112B1Pharmaceutical uses and synthesis of nicotinamidesUCB SA·Filed 2003·Granted Dec 19, 2006·6 cites·2 claims
- 3474US2025135018A1Camptothecin peptide conjugatesSEAGEN INC·Filed 2023·Application pending·0 cites
- 3573US2024247030A1Targeted delivery of tertiary amine-containing drug substancesSEAGEN INC·Filed 2023·Application pending·0 cites
- 3672US2025073348A1Camptothecin conjugatesSEAGEN INC·Filed 2024·Application pending·0 cites
- 3769US2024424126A1Ceacam5 antibody-drug conjugates and methods of use thereofSANOFI SA·Filed 2024·Application pending·0 cites
- 3868US7235578B2Processes for preparing 3-substituted 1-(chloromethyl)-1,2-dihydro-3H-[ring fused indol-5-yl-(amine-derived)] compounds and analogues thereof, and to products obtained therefromAUCKLAND UNISERVICES LTD·Filed 2003·Granted Jun 26, 2007·3 cites·8 claims
- 3968US2021047404A1Cd33 antibodies and use of same to treat cancerSEATTLE GENETICS INC·Filed 2020·Application pending·0 cites
- 4068US2024366779A1Selective drug release from internalized conjugates of biologically active compoundsSEAGEN INC·Filed 2024·Application pending·0 cites
- 4167US2024226313A1Ceacam5 antibody-drug conjugates and methods of use thereofSANOFI SA·Filed 2023·Application pending·0 cites
- 4265US2022193069A1Camptothecin peptide conjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 4364US2017189542A1Beta-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 4463US12194321B2Camptothecin conjugatesSEAGEN INC·Filed 2019·Granted Jan 14, 2025·0 cites·43 claims
- 4563US2018228916A1Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2018·Application pending·0 cites
- 4663US2022054650A1Methylene Carbamate Linkers for use with Targeted-Drug ConjugatesSEAGEN INC·Filed 2021·Application pending·0 cites
- 4762US2016361424A1Beta-glucuronide-linker drug conjugatesSEATTLE GENETICS INC·Filed 2016·Application pending·0 cites
- 4862US2025248994A1Camptothecin conjugatesSEAGEN INC·Filed 2025·Application pending·0 cites
- 4959US2017143846A1Targeted pyrrolobenzodiazapine conjugatesSEATTLE GENETICS INC·Filed 2017·Application pending·0 cites
- 5059US2024207427A1Selective drug release from internalized conjugates of biologically active compoundsSEAGEN INC·Filed 2023·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Scott Jeffrey files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →